Abstract
Of 9,557 deliveries, 1,806 patients received intranasal oxytocin. Thirteen hundred and fifty-seven, or 75 per cent, received it for elective stimulation of labor. Four hundred forty-nine, or 25 per cent, received it for induction of labor. There was a total success rate of induction of 88 per cent. There was an over-all cesarean rate of 1.5 per cent, and there were no major maternal complications. There were 11 cervical lacerations, no ruptured uteri, and one inversion of the uterus. There was a total of 6 depressed infants, one of whom required prolonged hospitalization. There were 2 fetal deaths which could indirectly be related to the use of intranasal oxytocin.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
